Cargando…
COVID-19 Associated Mucormycosis (CAM): A Single Hospital-Based Study
BACKGROUND: Opportunistic fungal infections like Mucormycosis in Coronavirus Disease 2019 (COVID-19) patients have posed a great challenge to health care professionals, especially in developing countries like India. Hence, there is a need to understand the biological behaviour of COVID-19 associated...
Autores principales: | Vijapur, Manjunath M., Kattimani, Vasanth, Varsha, VK, Girish, HC, Kamat, Mamata, Ram, Bhargav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364634/ https://www.ncbi.nlm.nih.gov/pubmed/35968169 http://dx.doi.org/10.4103/jomfp.jomfp_152_22 |
Ejemplares similares
-
COVID-19-associated mucormycosis of head-and-neck region: A systematic review
por: Kamat, Mamata, et al.
Publicado: (2022) -
A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM)
por: Osman, Nermin A., et al.
Publicado: (2023) -
COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert?
por: Farias, Luís Arthur Brasil Gadelha, et al.
Publicado: (2021) -
COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
por: Hussain, Salman, et al.
Publicado: (2021) -
COVID-19 associated mucormycosis (CAM): A tale of two pathogens
por: Pustake, Manas, et al.
Publicado: (2021)